IL6 and cancer: Cancer-associated fibroblasts (CAFs) are a dominant stromal cell type in the TME that are activated from resting fibroblasts via the NF-κB and JAK-STAT pathways once cancer cells or immune cells release signaling molecules such as TGFβ, RTK ligands, IL1β and IL6 [18].